X Cui, X Jing - Journal of Ovarian Research, 2024 - Springer
Premature ovarian insufficiency (POI) is defined as onset of menopause characterized by amenorrhea, hypergonadotropism, and hypoestrogenism, before the age of 40 years. The …
M Gowkielewicz, A Lipka, W Zdanowski… - Frontiers in …, 2024 - frontiersin.org
Anti-Müllerian hormone (AMH) is a peptide belonging to the transforming growth factor beta superfamily and acts exclusively through its receptor type 2 (AMHR2). From the 8th week of …
E Chatziandreou, A Eustathiou, A Augoulea, E Armeni… - Geriatrics, 2023 - mdpi.com
This study aimed to assess an eligible cut-off value of anti-Müllerian hormone (AMH) to detect ovarian senescence in a group of premenopausal Greek women to evaluate the …
L Casadei, I Nacci, V Vicomandi, RP Sorge… - Reproductive …, 2023 - mdpi.com
This study, carried out on 94 women with polycystic ovary syndrome (PCOS) and 176 controls without it, investigated the influence of body mass index (BMI) on serum levels of …
Z Yarkiner, FK Boynukalın, Ö Coban - Reproductive Sciences, 2024 - Springer
The utilization of donor eggs has broadened the options for Assisted Reproductive Technology (ART) among women facing challenges with egg quantity or quality. Given that …
Methods This cross-sectional type of observational study included 101 healthy infertile women aged 20-35 years and with low serum AMH. The mean difference in basal AFC …
Background: Anti-Müllerian hormone (AMH) has lately been connected to polycystic ovary syndrome (PCOS) in a growing body of research, even though hyperandrogenism is one of …
The fertility journey, spanning preconception to postpartum, is critically underserved by traditional healthcare systems, which often fail to provide continuous, personalized care …